Radioiodinated hypericin: its biodistribution, necrosis avidity and therapeutic efficacy are influenced by formulation. - Wikidata - awgldk - TriplyDB

Radioiodinated hypericin: its biodistribution, necrosis avidity and therapeutic efficacy are influenced by formulation.

Radioiodinated hypericin: its biodistribution, necrosis avidity and therapeutic efficacy are influenced by formulation.

http://www.wikidata.org/entity/Q30660860

about

An overview of translational (radio)pharmaceutical research related to certain oncological and non-oncological applications.Illuminating necrosis: From mechanistic exploration to preclinical application using fluorescence molecular imaging with indocyanine green.Pre-clinical Evaluation of a Cyanine-Based SPECT Probe for Multimodal Tumor Necrosis Imaging.Effects of skeleton structure on necrosis targeting and clearance properties of radioiodinated dianthrones.Effects of Glycosylation on Biodistribution and Imaging Quality of Necrotic Myocardium of Iodine-131-Labeled Sennidins.Experimental evaluation of radioiodinated sennoside B as a necrosis-avid tracer agent.Radiopharmaceutical study on Iodine-131-labelled hypericin in a canine model of hepatic RFA-induced coagulative necrosis.Sodium cholate, a solubilizing agent for the necrosis avid radioiodinated hypericin in rabbits with acute myocardial infarction.

P2860

Q34093032-9DD804C5-D0B3-44C9-9210-8DE46B7DCE5C Q36569572-B86B49D3-018F-45C9-B7E5-33BD0D4156C8 Q37389690-1814E7AF-7FC4-4EF5-8927-96447C20218B Q38818263-59FF562B-D6CB-4F0B-8E5A-B8BA7430C937 Q39771386-66720405-D659-44F3-9EEF-41400FA32A23 Q53044553-F5FA4691-9688-4884-9895-3811D88F091F Q53060211-0D04EB3F-6F61-4E88-B259-CFE29E5A90CF Q53640087-28F0EB93-54F7-4157-86C0-3E81C6DCFC08

P2860

Radioiodinated hypericin: its biodistribution, necrosis avidity and therapeutic efficacy are influenced by formulation.

http://www.wikidata.org/entity/Q30660860

description

2013 nî lūn-bûn

@nan

2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Radioiodinated hypericin: its ...... are influenced by formulation.

@ast

Radioiodinated hypericin: its ...... are influenced by formulation.

@en

type

label

Radioiodinated hypericin: its ...... are influenced by formulation.

@ast

Radioiodinated hypericin: its ...... are influenced by formulation.

@en

prefLabel

Radioiodinated hypericin: its ...... are influenced by formulation.

@ast

Radioiodinated hypericin: its ...... are influenced by formulation.

@en

P1433

Q30660860-B41BD5AA-D5F2-43C9-B851-AB89A84B6929

P1476

Q30660860-8E3CB4CE-72F2-4152-ADBB-0AB7D5297CB3

P2093

Q30660860-28484D14-D0EA-4C00-BB8E-8FC500E7BBA5

Q30660860-292E6B7B-2712-4270-8B6D-22BF875FB0C8

Q30660860-2F2EFC3C-D3A9-4775-B3F6-49A17630FFE7

Q30660860-37EA3590-B350-44AB-AF99-B3F0209560A2

Q30660860-4663C9FF-E5BB-4D27-9CB0-6B068C35CE7E

Q30660860-4E9EE5A0-1894-43C7-896D-CB9DCACAC305

Q30660860-BC446EFA-9D16-417B-B748-24002228B1FA

Q30660860-CEF48203-F014-4D4F-A31D-21DEB61C93C3

Q30660860-E0D105E5-0E6E-4AA8-880E-5D2C092F3D23

Q30660860-EDA24298-D9E4-4BBE-8E8F-DC20A4BC85E0

P2860

Q30660860-04877B8B-7300-4EEA-BF90-973945A1EABF

Q30660860-0738ECC6-D65E-4519-B619-602C20951718

Q30660860-0FBE5EE5-4CE5-485D-8531-263A569AEAA3

Q30660860-1CA41296-8429-4E3C-9AA3-EF08D156477B

Q30660860-1D486EED-2407-45B9-ACC0-F22EB4BDC8E9

Q30660860-2E209C62-1DC7-46FB-9845-3DF21277CF3F

Q30660860-32E775AB-A1E8-4143-A6B3-312575AD10CE

Q30660860-39D5FB19-64C2-4959-8214-05FA31E3DA7B

Q30660860-4327B512-C244-4F04-BF10-AD130FCDEB12

Q30660860-5510435E-93DB-4FF0-89AF-B92DBBBE725E

P304

Q30660860-973BAAE3-64F1-4352-8540-A2612F851B99

P31

Q30660860-F443A71B-2750-4449-B093-B668BBFDE924

P356

Q30660860-611B1470-1834-4E56-B7B1-8798C5B9EAB4

P433

Q30660860-1B11853B-9D81-4F68-81F1-ADFEF20D6EAB

P478

Q30660860-B3A68F32-254E-40AD-B619-36EB0836C6A2

P50

Q30660860-168B1E4B-9336-400C-BF0F-510E9A5A861A

Q30660860-215C2062-88BD-442B-87C1-98C826551605

Q30660860-330909C1-457C-4148-A49B-F1616123FD90

P577

Q30660860-CE4F1EB5-D2B8-4F70-8562-AE2B834A07DC

P698

Q30660860-811ED1E4-05D8-43BF-B5AB-2235868E94D4

P356

S11095-013-1159-4

P1433

Pharmaceutical Research

P1476

Radioiodinated hypericin: its ...... are influenced by formulation.

@en

P2093

Alfons Verbruggen

http://www.w3.org/2001/XMLSchema#string

Feng Chen

http://www.w3.org/2001/XMLSchema#string

Jian Zhang

http://www.w3.org/2001/XMLSchema#string

Junjie Li

http://www.w3.org/2001/XMLSchema#string

Marlein Miranda Cona

http://www.w3.org/2001/XMLSchema#string

Matthias Bauwens

http://www.w3.org/2001/XMLSchema#string

Raymond Oyen

http://www.w3.org/2001/XMLSchema#string

Yicheng Ni

http://www.w3.org/2001/XMLSchema#string

Yuanbo Feng

http://www.w3.org/2001/XMLSchema#string

Ziping Sun

http://www.w3.org/2001/XMLSchema#string

P2860

Therapeutic radiopharmaceuticals

Tumour-cell invasion and migration: diversity and escape mechanisms

Biodistribution of hypericin in orthotopic transitional cell carcinoma bladder tumors: implication for whole bladder wall photodynamic therapy.

Intratumoral hypericin and KTP laser therapy for transplanted squamous cell carcinoma.

Photodynamic therapy and tumor imaging of hypericin-treated squamous cell carcinoma.

Bifunctional chelators for therapeutic lanthanide radiopharmaceuticals.

Hypericin--a new antiviral and antitumor photosensitizer: mechanism of action and interaction with biological macromolecules.

Topical anti-inflammatory activity of extracts and compounds from Hypericum perforatum L.

Exploring theranostic potentials of radioiodinated hypericin in rodent necrosis models.

Sequential systemic administrations of combretastatin A4 Phosphate and radioiodinated hypericin exert synergistic targeted theranostic effects with prolonged survival on SCID mice carrying bifocal tumor xenografts.

P304

278-290

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11095-013-1159-4

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

Yeranddy A Alpizar

P577

2013-08-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23934256

http://www.w3.org/2001/XMLSchema#string